THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM

被引：0
|
作者：
Choi, Bum Soon [1 ]
Choi, Sun Ryoung [1 ]
Park, Hoon Suk [1 ]
Hong, Yu Ah [1 ]
Chung, Byung Ha [1 ]
Kim, Young Soo [1 ]
Yang, Chul Woo [1 ]
Kim, Yong-Soo [1 ]
Park, Cheol Whee [1 ]
机构：
[1] Catholic Univ Korea, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：442 / 442
页数：1
相关论文
共 50 条
  • [21] Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism
    Ishimura, E.
    Okuno, S.
    Tsuboniwa, N.
    Ichii, M.
    Yamakawa, K.
    Yamakawa, T.
    Shoji, S.
    Nishizawa, Y.
    Inaba, M.
    CLINICAL NEPHROLOGY, 2011, 76 (04) : 259 - 265
  • [22] EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM INADEQUATELY CONTROLLED WITH CINACALCET
    Takahashi, Hiroo
    Komaba, Hirotaka
    Takahashi, Ryo
    Takahashi, Yuichiro
    Fukagawa, Masafumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [23] Association of Nodular Hyperplasia With Resistance to Cinacalcet Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
    Hirai, Takayuki
    Nakashima, Ayumu
    Takasugi, Norihisa
    Yorioka, Noriaki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (06) : 577 - 582
  • [24] IS THE CHANGE FROM CINACALCET TO ETELCALCETIDE SAFE AND EFFECTIVE IN PATIENTS ON HEMODIALYSIS WITH SECONDARY HYPERPARATHYROIDISM?
    Hadad Arrascue, Fernando
    Araque, Alicia
    Amair, Ruth
    Rosique, Florentina
    Perez Perez, Antonio
    Andreu Munoz, Alberto
    Cabezuelo-Romero, Juan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1740 - 1740
  • [25] Analysis of the efficacy and factors influencing the response of secondary hyperparathyroidism patients on hemodialysis to cinacalcet
    Segura Torres, P.
    Borrego Utiel, F. J.
    Sanchez Perales, M. C.
    Garcia Cortes, M. J.
    Biechy Baldan, M. M.
    Perez Banasco, V.
    NEFROLOGIA, 2010, 30 (04): : 443 - 451
  • [26] Six cases of successful cinacalcet cessation in hemodialysis patients treated for secondary hyperparathyroidism
    Jean, Guillaume
    Chazot, Charles
    Charra, Bernard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 173 - 173
  • [27] Cinacalcet Improves Endothelial Dysfunction and Cardiac Hypertrophy in Patients on Hemodialysis with Secondary Hyperparathyroidism
    Choi, Sun Ryoung
    Lim, Ji Hee
    Kim, Min Young
    Hong, Yu-Ah
    Chung, Byung Ha
    Chung, Sungjin
    Choi, Bum Soon
    Yang, Chul Woo
    Kim, Yong-Soo
    Chang, Yoon Sik
    Park, Cheol Whee
    NEPHRON CLINICAL PRACTICE, 2012, 122 (1-2): : 1 - 8
  • [28] Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis
    Imafuku, Tadashi
    Tanaka, Motoko
    Tokunaga, Koki
    Miyamura, Shigeyuki
    Kato, Hiromasa
    Tanaka, Shoma
    Nakano, Takehiro
    Hirata, Kenshiro
    Kadowaki, Daisuke
    Maeda, Hitoshi
    Matsushita, Kazutaka
    Otagiri, Masaki
    Komaba, Hirotaka
    Fukagawa, Masafumi
    Watanabe, Hiroshi
    Maruyama, Toru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (10) : 1583 - 1590
  • [29] Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    NEPHRON, 2018, 139 (04) : 286 - 292
  • [30] Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Wiecek, Andrzej
    BMC NEPHROLOGY, 2016, 17 : 1 - 7
12345